Abstract
This study evaluated the results of treating heart failure after myocardial infarction by intracoronary transplantation of autologous bone marrow stem cells at the Vietnam National Heart Institute. At 12 months, heart failure improved significantly more in the patients who received autologous stem cells than in the control group, as shown by improvements in NYHA class, proBNP and left ventricular ejection fraction (EF) measured by echocardiography, left ventriculography and cardiac magnetic resonance imaging (p < 0.05). Conclusion: The methods of isolating, transporting, preserving and transplanting autologous bone marrow stem cells for the treatment of heart failure after myocardial infarction are feasible, safe and effective.